Bank Of Montreal Abb Vie Inc. Call Options Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $4.1 Million - $4.98 Million	25,000 Added 22.22%	137,500 $27.2 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $18 Million - $20.5 Million	112,500 New	112,500 $20.5 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $4.73 Million - $5.27 Million	45,000 New	45,000 $5.07 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.